Standout Papers
Citation Impact
Citing Papers
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli
2012
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Primary Prevention of Ischemic Stroke
2006
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Incidence of malignant neoplasms among HIV-infected persons in Scotland
2003
The risk of cancer in HIV-infected people in southeast England: a cohort study
2004
An integrated map of genetic variation from 1,092 human genomes
2012 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Predictive Capacity of Pre-Donation GFR and Renal Reserve Capacity for Donor Renal Function After Living Kidney Donation
2006
Insights into α1 adrenoceptor function in health and disease from transgenic animal studies
2003
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community
2002
“U” curve association of blood pressure and mortality in hemodialysis patients
1998
Heart-Rate Recovery Immediately after Exercise as a Predictor of Mortality
1999 Standout
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
2002
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
2001
Chronic Kidney Disease and Mortality Risk
2006
Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension
2002
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases
1999 StandoutNobel
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
“Strict” blood pressure control and progression of renal disease in hypertensive nephrosclerosis
1995
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
2013 Standout
Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic
2005
Guidelines for the Primary Prevention of Stroke
2010
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
1999
Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study
2002
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
High prevalence of cardiac and extracardiac target organ damage in refractory hypertension
2001
Gene–environment-wide association studies: emerging approaches
2010
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
2013
Phosphorylation and Desensitization of the Human β1-Adrenergic Receptor
1995 StandoutNobel
Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension
2001
High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension
2001
Microalbuminuria in Nondiabetic Adults
1998
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial
2005
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Phosphorylation of the Type 1A Angiotensin II Receptor by G Protein-coupled Receptor Kinases and Protein Kinase C
1996 StandoutNobel
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Effect of dietary fiber intake on blood pressure
2003
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
2009
Association of Cancer With AIDS-Related Immunosuppression in Adults
2001
Primary Prevention of Hypertension<SUBTITLE>Clinical and Public Health Advisory From the National High Blood Pressure Education Program</SUBTITLE>
2002
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?
1998
Obesity and Cardiovascular Disease
2009 Standout
Impact of renal failure on the risk of myocardial infarction and death
2002
Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial
2004
Characterization of the G Protein-coupled Receptor Kinase GRK4
1996 StandoutNobel
Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
2015
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
The role of spironolactone in the treatment of patients with refractory hypertension
2002
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
Renal Function and Intensive Lowering of Blood Pressure in Hypertensive Participants of the Hypertension Optimal Treatment (HOT) Study
2001
Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups
2002
Epidemiologic findings on body mass and blood pressure in adults
1991
Importance of Estimated Functional Capacity as a Predictor of All-Cause Mortality Among Patients Referred for Exercise Thallium Single-Photon Emission Computed Tomography: Report of 3,400 Patients From a Single Center
1997
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
1998 Standout
The renal risks of smoking
1997
The Role of Sequestration in G Protein-coupled Receptor Resensitization
1997 StandoutNobel
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
1996
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension
1998
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease
2001
Effect of Dietary Fiber and Protein Intake on Blood Pressure: A Review of Epidemiologic Evidence
1999
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart.
1995
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly
2003
Cardiovascular disease risk status in elderly persons with renal insufficiency
2002
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Cardiovascular disease and chronic renal disease: A new paradigm
2000
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis
2005
The Hallmarks of Aging
2013 Standout
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
2001
Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I
2002
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Subclinical Hypertensive Heart Disease in Black Patients With Elevated Blood Pressure in an Inner-City Emergency Department
2012
A Practical Approach to Achieving Recommended Blood Pressure Goals in Diabetic Patients
2001
Ethnicity and Renal Disease: Lessons From the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study
1993
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data
1993
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting
2009
Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial
2006
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
On the importance of estimating renal function for cardiovascular risk assessment
2004
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial
1997
Importance of Systolic Blood Pressure in Older Americans
2000
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001 StandoutNobel
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Serum Creatinine Concentration and Risk of Cardiovascular Disease
1997
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
2001
Preserving renal function in adults with hypertension and diabetes: A consensus approach
2000
Primary Prevention of Ischemic Stroke
2001
Persistence of Reduction in Blood Pressure and Mortality of Participants in the Hypertension Detection and Follow-up Program
1988
Effects of Calcium Antagonists on Renal Hemodynamics and Progression of Nondiabetic Chronic Renal Disease
1994
Systematic Review: Antihypertensive Drug Therapy in Black Patients
2004
β 2 -Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein
1998 StandoutNobel
Effects of Comprehensive Lifestyle Modification on Blood Pressure Control
2003
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Dietary Approaches to Prevent and Treat Hypertension
2006
Myocyte Adrenoceptor Signaling Pathways
2003 StandoutScienceNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Hypertensive Nephrosclerosis as a Relevant Cause of Chronic Renal Failure
2001
Control of Hypertension in Adults With Chronic Kidney Disease in the United States
2005
Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections
2008
Long-Term Effects of Weight Loss and Dietary Sodium Reduction on Incidence of Hypertension
2000
Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases.
1996 StandoutNobel
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
New Targets and Screening Approaches in Antimicrobial Drug Discovery
2005
Long-Term Absolute Benefit of Lowering Blood Pressure in Hypertensive Patients According to the JNC VI Risk Stratification
2000
Prevalence of Hypertension in the US Adult Population
1995 Standout
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Primary Prevention of Ischemic Stroke
2001
Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites
1997
End-stage renal disease in African-American and white men. 16-year MRFIT findings.
1997
Management of High Blood Pressure in Blacks
2010
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure
2000
Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the β1-adrenergic receptor
1999 StandoutNobel
Large-scale analysis of the human and mouse transcriptomes
2002 StandoutNobel
Prognostic Significance of Serum Creatinine and Uric Acid in Older Chinese Patients With Isolated Systolic Hypertension
2001
Prevalence, Awareness, Treatment, and Control of Hypertension in China
2002
Alcohol, hypertension and the cardiovascular system: a critical appraisal
1997
Prevalence, Awareness, Treatment, and Control of Hypertension in China
2008
Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril
2006
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
2001
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Charles E. Ford being referenced
Imputing gene–treatment interactions when the genotype distribution is unknown using case‐only and putative placebo analyses—a new method for the Genetics of Hypertension Associated Treatment (GenHAT) study
2004
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant −455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study
2009
Operational Aspects of Terminating the Doxazosin Arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2001
Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2011
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002
The Discovery of Linezolid, the First Oxazolidinone Antibacterial Agent
2001
Blood Pressure and End-Stage Renal Disease in Men
1996 Standout
Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2008
Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program.
1991
ASCERTAINMENT OF VITAL STATUS THROUGH THE NATIONAL DEATH INDEX AND THE SOCIAL SECURITY ADMINISTRATION
1985
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
1989
Myocardial adrenergic denervation supersensitivity depends on a postreceptor mechanism not linked with increased cAMP production.
1992
HIV-Related Malignancies: Community-Based Study using Linkage of Cancer Registry and HIV Registry Data
1999
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
2008
The hypertension detection and follow-up program design, methods, and baseline characteristics and blood pressure response of the study population
1986
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2001
Cardiovascular Morbidity and Mortality in HDFP Patients 50-69 Years Old at Entry
1985
Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion.
1992
Pharmacogenetic Effect of the Stromelysin (MMP3) Polymorphism on Stroke Risk in Relation to Antihypertensive Treatment
2010